Psilocybin mushrooms for depression offer lasting benefits, with effects persisting months or even years after just one or two sessions, surpassing traditional treatments.

Microdosing psychedelics has gained popularity, but it poses hidden risks, particularly heart complications from chronic use. Responsible, medically supervised practices are needed to ensure safety.

Psychedelic therapy offers new hope for addiction recovery, showing remarkable success in treating alcohol, tobacco, and other substance use disorders, but regulatory and accessibility challenges remain.

Psilocybin mushrooms show potential as a breakthrough treatment for depression, offering hope for treatment-resistant patients, but legal hurdles and high costs remain challenges.

Psychedelic research is transforming mental health care, offering groundbreaking treatments like MDMA and psilocybin for conditions like PTSD and depression, with potential for lasting recovery.

Elon Musk's alleged use of psychedelics has sparked controversy, but media coverage often sensationalizes mental health treatments, reinforcing stigma and missing critical medical context.

MDMA-assisted therapy is showing remarkable results in treating PTSD, with trials revealing lasting improvements in trauma processing and emotional healing, offering hope for those with treatment-resistant PTSD.

Psilocybin therapy shows promising results in treating alcohol use disorder by reshaping brain activity, enhancing decision-making, and reducing cravings, offering lasting recovery.

Microdosing psychedelics shows promise for ADHD symptoms in observational studies, but controlled trials reveal mixed results. Current evidence remains preliminary, requiring caution and professional guidance.

Multiple countries are legalizing psychedelics for medical use in 2025, with Australia, Canada, Netherlands, and Czech Republic leading evidence-based policy reform for mental health treatment.

Ketamine therapy shows promise for treatment-resistant PTSD, offering rapid symptom relief through neuroplasticity enhancement. However, effects may be temporary and require careful medical supervision.

Tracing psychedelic clinical trials from the 1990s breakthrough studies to today's promising MDMA and psilocybin research, exploring the journey toward mainstream mental health treatment applications.

Entrepreneurs often face invisible mental health costs like burnout, hyper-responsibility, and identity shifts. Therapy helps founders navigate these struggles and rediscover authentic, sustainable leadership.

Psychedelic therapists face deep emotional and spiritual effects from clients' mystical journeys. Managing these vicarious experiences is key to therapist well-being and effective psychedelic-assisted therapy.

Startup founders often blur personal identity with business success, risking burnout and isolation. Therapy offers vital support to process emotions, build resilience, and maintain well-being beyond entrepreneurship.

The psychedelic therapy boom brings hope but high burnout risk for therapists. Learn how innovative supervision and burnout therapy help sustain mental health professionals in this evolving field.

This article explores how psychedelics are gaining attention in the business world for enhancing creativity, cognitive flexibility, and emotional resilience. It reviews current research, practical applications, and the ethical and legal considerations professionals should keep in mind as interest in these substances grows.

Psychedelic therapy is powerful—but also emotionally demanding for the therapists who provide it. This post explores why ongoing personal therapy is essential for psychedelic therapists, how it supports ethical practice, and what kind of care these healers need to stay grounded and effective.

This post explores what psychedelic integration therapy looks like in practice—how it helps individuals process their experiences, make meaning of insights, and create lasting change. Whether you're considering psychedelic therapy or supporting others, it offers a grounded look at this essential part of the healing process.

In this article, we explore where you can access psychedelic therapy, including the legal landscape and different types of substances like psilocybin, MDMA, and ketamine used in these treatments. From personal use to facilitated experiences and professional therapy, we dive into the options available in the U.S. and abroad.